← Back to headlines
Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?
Analysts are projecting a significant upside of over 180% for Allogene Therapeutics (ALLO), indicating strong confidence in the company's future growth and stock performance. The article explores the reasons behind this optimistic forecast.
12 Apr, 21:49 — 12 Apr, 21:49
Sources
Showing 1 of 1 sources
